AXOVANT Trademark

Trademark Overview

On Wednesday, May 30, 2018, a trademark application was filed for AXOVANT with the United States Patent and Trademark Office. The USPTO has given the AXOVANT trademark a serial number of 79238422. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, February 15, 2023. This trademark is owned by Axovant Sciences GmbH. The AXOVANT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and technological services, namely, medical research and scientific research and analysis; biomedical and pharmaceutical research services; research in the field of therapeutic biological and pharmaceutical preparations for diseases, disorders and conditions related to the central nervous system and neurology; pharmaceutical research and development; provision of information regarding scientific research in the field of pharmaceutical products and biomedicine
axovant

General Information

Serial Number79238422
Word MarkAXOVANT
Filing DateWednesday, May 30, 2018
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, February 15, 2023
Registration Number6109779
Registration DateTuesday, July 28, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 12, 2019

Trademark Statements

Goods and ServicesScientific and technological services, namely, medical research and scientific research and analysis; biomedical and pharmaceutical research services; research in the field of therapeutic biological and pharmaceutical preparations for diseases, disorders and conditions related to the central nervous system and neurology; pharmaceutical research and development; provision of information regarding scientific research in the field of pharmaceutical products and biomedicine

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeH - NOT AVAILABLE
Class Status DateWednesday, February 15, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAxovant Sciences GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameAxovant Sciences GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameAxovant Sciences GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Sunday, March 5, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sunday, March 5, 2023DEATH OF INTERNATIONAL REGISTRATION
Saturday, December 5, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, November 13, 2020FINAL DISPOSITION NOTICE SENT TO IB
Friday, November 13, 2020FINAL DISPOSITION PROCESSED
Wednesday, October 28, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 28, 2020REGISTERED-PRINCIPAL REGISTER
Friday, June 26, 2020REFUSAL PROCESSED BY IB
Tuesday, June 23, 2020TTAB RELEASE CASE TO TRADEMARKS
Tuesday, June 23, 2020OPPOSITION TERMINATED NO. 999999
Tuesday, June 23, 2020OPPOSITION DISMISSED NO. 999999
Saturday, June 6, 2020OPPOSITION INSTITUTED NO. 999999
Saturday, June 6, 2020OPPOSITION PAPERS RECEIVED AT TTAB
Thursday, June 4, 2020EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, June 2, 2020OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Tuesday, June 2, 2020OPPOSITION NOTICE (IB REFUSAL) CREATED
Friday, January 31, 2020NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, January 15, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 15, 2020NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, November 26, 2019EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, November 12, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 12, 2019PUBLISHED FOR OPPOSITION
Friday, November 8, 2019NOTIFICATION PROCESSED BY IB
Wednesday, October 23, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 23, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 23, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 10, 2019ASSIGNED TO LIE
Tuesday, October 8, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 8, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 7, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 7, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, April 8, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, April 8, 2019FINAL REFUSAL E-MAILED
Monday, April 8, 2019FINAL REFUSAL WRITTEN
Monday, March 18, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, March 17, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, March 17, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 26, 2018REFUSAL PROCESSED BY IB
Thursday, October 25, 2018NEW REPRESENTATIVE AT IB RECEIVED
Saturday, September 22, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, September 22, 2018REFUSAL PROCESSED BY MPU
Wednesday, September 19, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, September 18, 2018NON-FINAL ACTION WRITTEN
Tuesday, September 18, 2018ASSIGNED TO EXAMINER
Wednesday, August 29, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, August 18, 2018APPLICATION FILING RECEIPT MAILED
Tuesday, August 14, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 13, 2018LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, August 9, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

axovant research pharmaceutical scientific services field central neurology system development nervous